Talis Biomedical Corp (OQ:TLIS)

Business Focus: Biotechnology & Medical Research

Feb 15, 2024 11:30 pm ET

TALIS ALERT: Bragar Eagel & Squire, P.C. is Investigating Talis Biomedical Corporation on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm

Jan 09, 2024 09:00 pm ET

TALIS ALERT: Bragar Eagel & Squire, P.C. is Investigating Talis Biomedical Corporation on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm

Nov 14, 2023 08:00 am ET

Talis Biomedical Announces Exploration of Strategic Alternatives and Cost Reduction Plan to Preserve Cash

Talis Biomedical Corporation (Nasdaq: TLIS), a diagnostic company dedicated to advancing health equity and outcomes through the delivery of accurate infectious disease testing in the moment of need, at the point of care, today announced it has...

Aug 10, 2023 04:05 pm ET

Talis Biomedical Announces Second Quarter 2023 Financial Results and Business Update

Aug 03, 2023 08:00 am ET

Talis Biomedical to Report Second Quarter 2023 Financial Results and Provide a Business Update on August 10, 2023

Aug 02, 2023 08:00 am ET

Talis Biomedical Announces Andrew Lukowiak, Ph.D., as President and Chief Scientific Officer (CSO)

Jul 27, 2023 08:00 am ET

New Data Presented at the Infectious Disease Society for Obstetrics and Gynecology (IDSOG) Annual Meeting Differentiate Talis Biomedical’s Women’s and Sexual Health Product Menu

Talis Biomedical Corporation (Nasdaq: TLIS) today announced new data supporting the development of its planned CT/NG/TV and vaginal infection panels. Results from these studies, presented in poster sessions at the 2023 IDSOG Annual Meeting in...

Jul 24, 2023 08:00 am ET

Talis Biomedical Regains Compliance with Nasdaq Minimum Bid Price Requirement

Jul 05, 2023 08:00 am ET

Talis Biomedical Announces 1-for-15 Reverse Stock Split

Jun 21, 2023 11:13 pm ET

TALIS ALERT: Bragar Eagel & Squire, P.C. is Investigating Talis Biomedical Corporation on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm

Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, is investigating potential claims against Talis Biomedical Corporation (NASDAQ: TLIS) on behalf of long-term stockholders following a class action complaint that was filed against Talis on March 8, 2022 with a Class Period relating to stock purchases made pursuant to the Company’s February 2021 IPO. Our investigation concerns whether the board of directors of Talis have breached their fiduciary duties to the company.

May 23, 2023 08:00 am ET

Talis Biomedical Appoints Former Roche Molecular CEO Heiner Dreismann to Board of Directors, Announces Former Genomic Health CEO Kim Popovits as Lead Independent Director

May 11, 2023 04:05 pm ET

Talis Biomedical Announces Business Update and First Quarter 2023 Financial Results

May 09, 2023 12:43 pm ET

Talis Biomedical Corporation (TLIS) Investor News: Robbins LLP Reminds Investors it is Investigating TLIS on Behalf of Shareholders

Shareholder rights law firm Robbins LLP is investigating Talis Biomedical Corporation (NASDAQ: TLIS) to determine whether certain Talis officers and directors violated securities laws and breached fiduciary duties to shareholders in connection with...

May 04, 2023 08:00 am ET

Talis Biomedical to Provide Business Update and Financial Results on May 11, 2023

May 02, 2023 02:38 pm ET

Talis Biomedical Corporation (TLIS) Stockholders: Robbins LLP is Investigating TLIS on Behalf of Shareholders

Mar 22, 2023 04:05 pm ET

Talis Announces Fourth Quarter and Full Year 2022 Financial Results

Nov 03, 2022 04:05 pm ET

Talis Biomedical Reports Third Quarter 2022 Financial Results

Aug 02, 2022 04:05 pm ET

Talis Biomedical Provides Business Update and Reports Second Quarter Financial Results

Talis Biomedical Corporation (Nasdaq: TLIS), a company dedicated to advancing health equity and outcomes through the delivery of accurate infectious disease testing in the moment of need, at the point of care, today provided a business update and...

May 10, 2022 04:05 pm ET

Talis Biomedical Announces First Quarter 2022 Financial Results

Apr 26, 2022 08:00 am ET

Talis Biomedical to Announce First Quarter 2022 Financial Results on May 10, 2022

Talis Biomedical Corporation ("TLIS"), a company dedicated to advancing health equity and outcomes through the delivery of accurate infectious disease testing in the moment of need, at the point of care, today announced that it will report first...

Mar 29, 2022 04:01 pm ET

Lifshitz Law PLLC Announces Investigations of First Solar, Inc. (NASDAQ: FSLR), Oak Street Health, Inc. (NYSE: OSH), Talis Biomedical (NASDAQ: TLIS), and Talkspace Inc. (NASDAQ: TALK)

First Solar, Inc. (NASDAQ: FSLR) Lifshitz Law PLLC announces that a class action complaint was filed on behalf of shareholders of First Solar alleging that Defendants made repeated misrepresentations to investors regarding the development of...

Mar 15, 2022 04:05 pm ET

Talis Biomedical Provides Business Update and Reports Fourth Quarter and Full Year 2021 Financial Results

Mar 08, 2022 05:00 am ET

TLIS ALERT: The Klein Law Firm Announces a Lead Plaintiff Deadline of March 8, 2022 in the Class Action Filed on Behalf of Talis Biomedical Corporation Shareholders

NEW YORK, March 8, 2022 /PRNewswire/ -- The Klein Law Firm announces that a class action complaint has been filed on behalf of shareholders of Talis Biomedical Corporation (NASDAQ: TLIS) alleging that the Company violated federal securities laws.

Mar 07, 2022 07:51 am ET

Final Deadline Reminder: Kessler Topaz Meltzer & Check, LLP Reminds Investors of Lead Plaintiff Deadline in Securities Fraud Class Action Lawsuit Filed Against Talis Biomedical Corporation (TLIS)

RADNOR, Pa., March 7, 2022 /PRNewswire/ -- The law firm of Kessler Topaz Meltzer & Check, LLP (www.ktmc.com) informs investors that a securities class action lawsuit has been filed against Talis Biomedical Corporation ("Talis") (NASDAQ: TLIS). The action charges Talis with violations of the federal securities laws, including omissions and fraudulent misrepresentations relating to the company's business, operations, and prospects. As a result of Talis' materially misleading statements to the public, Talis investors have suffered significant losses.

Mar 07, 2022 05:00 am ET

CLASS ACTION ALERT: The Law Offices of Vincent Wong Remind Talis Investors of a Lead Plaintiff Deadline of March 8, 2022

NEW YORK, March 7, 2022 /PRNewswire/ -- Attention Talis Biomedical Corporation ("Talis") (NASDAQ: TLIS) shareholders:

Mar 06, 2022 09:00 pm ET

Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Bright Health, First Solar, Talis, and Talkspace and Encourages Investors to Contact the Firm

Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, reminds investors that class actions have been commenced on behalf of stockholders of Bright Health Group, Inc. (NYSE: BHG), First Solar, Inc. (NASDAQ: FSLR), Talis...

Mar 06, 2022 06:45 pm ET

TLIS FINAL DEADLINE TUESDAY: ROSEN, TOP RANKED GLOBAL COUNSEL, Encourages Talis Biomedical Corporation Investors with Losses to Secure Counsel Before Important March 8 Deadline in Securities Class Act

WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Talis Biomedical Corporation (NASDAQ: TLIS) pursuant and/or traceable to the registration statement and prospectus (collectively, the “Registration...

Mar 06, 2022 12:27 pm ET

TLIS 2-DAY DEADLINE ALERT: Hagens Berman, National Trial Attorneys, Encourages Talis Biomedical Corporation (TLIS) Investors with Losses to Contact Firm’s Attorneys Before Application Deadline in Secu

Hagens Berman urges Talis Biomedical Corporation (NASDAQ: TLIS) investors with significant losses to submit your losses now. A securities class action has been filed concerning defendants’ representations during Talis’ Feb. 2021 initial public...

Mar 05, 2022 05:03 pm ET

TUESDAY DEADLINE: Talis Biomedical Corporation Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit - TLIS

SAN DIEGO, March 5, 2022 /PRNewswire/ -- Robbins Geller Rudman & Dowd LLP announces that purchasers of Talis Biomedical Corporation (NASDAQ: TLIS) common stock pursuant and/or traceable to the registration statement and prospectus (collectively, the "Registration Statement") issued in connection with Talis Biomedical's February 12, 2021 initial public offering ("IPO") have until this upcoming Tuesday, March 8, 2022 to seek appointment as lead plaintiff in Modrak v. Talis Biomedical Corporation, No. 22-cv-00105. Initiated on January 7, 2022 in the Northern District of California, the Tal

Mar 04, 2022 09:04 pm ET

TALIS BIOMEDICAL DEADLINE ALERT: Bragar Eagel & Squire, P.C. Reminds Investors that a Class Action Lawsuit Has Been Filed Against Talis Biomedical Corporation and Encourages Investors to Contact the F

Bragar Eagel & Squire, P.C., a nationally recognized stockholder rights law firm, announces that a class action lawsuit has been filed against Talis Biomedical Corporation (“Talis Biomedical” or the “Company”) (NASDAQ: TLIS) in the United States District Court for the Northern District of California on behalf of all persons and entities who purchased or otherwise acquired Talis Biomedical securities pursuant and/or traceable to the February 12, 2021 IPO. Investors have until March 8, 2022 to apply to the Court to be appointed as lead plaintiff in the lawsuit.

Mar 04, 2022 08:30 pm ET

TUESDAY DEADLINE: Talis Biomedical Corporation Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit – TLIS

Robbins Geller Rudman & Dowd LLP announces that purchasers of Talis Biomedical Corporation (NASDAQ: TLIS) common stock pursuant and/or traceable to the registration statement and prospectus (collectively, the “Registration Statement”) issued in connection with Talis Biomedical’s

Mar 04, 2022 10:06 am ET

TLIS Investor Alert: Bronstein, Gewirtz & Grossman, LLC Reminds Talis Biomedical Corporation Investors With Losses Exceeding $150K of Class Action and Lead Deadline: March 8, 2022

Mar 04, 2022 09:48 am ET

Deadline in 6 Days: Kessler Topaz Meltzer & Check, LLP Reminds Investors of Filing Deadline in Class Action Lawsuit against Talis Biomedical Corporation (TLIS)

The law firm of Kessler Topaz Meltzer & Check, LLP (www.ktmc.com) informs investors that a securities class action lawsuit has been filed in the United States District Court for the Northern District of California against Talis Biomedical...

Mar 04, 2022 05:00 am ET

TLIS SHAREHOLDER ALERT: Jakubowitz Law Reminds Talis Shareholders Of A Lead Plaintiff Deadline Of March 8, 2022

NEW YORK, March 4, 2022 /PRNewswire/ -- Jakubowitz Law announces that a securities fraud class action lawsuit has commenced on behalf of shareholders of Talis Biomedical Corporation (NASDAQ: TLIS).

Mar 03, 2022 11:20 am ET

Kessler Topaz Meltzer & Check, LLP: Securities Fraud Class Action Filed Against Talis Biomedical Corporation with Lead Plaintiff Deadline Approaching

The law firm of Kessler Topaz Meltzer & Check, LLP (

Mar 03, 2022 10:00 am ET

DEADLINE ALERT for BHG, TLIS, MP, TASK: Law Offices of Howard G. Smith Reminds Investors of Class Actions on Behalf of Shareholders

Law Offices of Howard G. Smith reminds investors that class action lawsuits have been filed on behalf of shareholders of the following publicly-traded companies. Investors have until the deadlines listed below to file a lead plaintiff motion....

Mar 03, 2022 05:00 am ET

TLIS LAWSUIT ALERT: Levi & Korsinsky Notifies Talis Biomedical Corporation Investors of a Class Action Lawsuit and Upcoming Deadline

NEW YORK, March 3, 2022 /PRNewswire/ -- Levi & Korsinsky, LLP notifies investors in Talis Biomedical Corporation ("Talis" or the "Company") (NASDAQ: TLIS) of a class action securities lawsuit.

Mar 02, 2022 10:00 am ET

MMAT, BHG & TLIS: Bronstein, Gewirtz & Grossman, LLC, A Nationally Recognized Firm, Reminds Investors Class Action Deadlines

Attorney Advertising -- Bronstein, Gewirtz & Grossman, LLC reminds investors that a class action lawsuit has been filed against the following publicly-traded companies. You can review a copy of the Complaints by visiting the links below or you may...

Mar 02, 2022 09:35 am ET

TLIS FINAL DEADLINE NOTICE: ROSEN, A GLOBALLY RECOGNIZED FIRM, Encourages Talis Biomedical Corporation Investors with Losses to Secure Counsel Before Important March 8 Deadline in Securities Class Act

Mar 02, 2022 05:00 am ET

SHAREHOLDER ALERT: The Gross Law Firm Notifies Shareholders of Talis Biomedical Corporation of a Class Action Lawsuit and a Lead Plaintiff Deadline of March 8, 2022 - (NASDAQ: TLIS)

NEW YORK, March 2, 2022 /PRNewswire/ -- The Gross Law Firm issues the following notice on behalf of shareholders of Talis Biomedical Corporation.

Mar 01, 2022 12:00 pm ET

Glancy Prongay & Murray LLP Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Talis Biomedical Corporation (TLIS)

Glancy Prongay & Murray LLP (“GPM”) reminds investors of the upcoming March 8, 2022 deadline to file a lead plaintiff motion in the class action filed on behalf of investors who purchased or otherwise acquired Talis Biomedical Corporation (“Talis”...

Mar 01, 2022 08:00 am ET

Talis Biomedical to Announce Fourth Quarter and Full Year Financial Results on March 15, 2022

Mar 01, 2022 05:00 am ET

TLIS ALERT: The Klein Law Firm Announces a Lead Plaintiff Deadline of March 8, 2022 in the Class Action Filed on Behalf of Talis Biomedical Corporation Shareholders

NEW YORK, March 1, 2022 /PRNewswire/ -- The Klein Law Firm announces that a class action complaint has been filed on behalf of shareholders of Talis Biomedical Corporation (NASDAQ: TLIS) alleging that the Company violated federal securities laws.

Feb 28, 2022 09:00 pm ET

Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Meta Materials, Bright Health, First Solar, and Talis and Encourages Investors to Contact the Firm

Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, reminds investors that class actions have been commenced on behalf of stockholders of Meta Materials, Inc. (NASDAQ: MMAT), Bright Health Group, Inc. (NYSE: BHG),...

Feb 28, 2022 03:33 pm ET

DEADLINE ALERT: ROSEN, SKILLED INVESTOR COUNSEL, Encourages Talis Biomedical Corporation Investors with Losses to Secure Counsel Before Important March 8 Deadline in Securities Class Action - TLIS

NEW YORK, Feb. 28, 2022 /PRNewswire/ -- WHY: New York, N.Y., February 28, 2022. Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Talis Biomedical Corporation (NASDAQ: TLIS) pursuant and/or traceable to the registration statement and prospectus (collectively, the "Registration Statement") issued in connection with the Company's February 2021 initial public offering ("IPO" or the "Offering"), of the important March 8, 2022 lead plaintiff deadline.

Feb 28, 2022 01:53 pm ET

TLIS 8-DAY DEADLINE ALERT: Hagens Berman, National Trial Attorneys, Encourages Talis Biomedical Corporation (TLIS) Investors with Losses to Contact Firm’s Attorneys Before Mar. 8th Deadline

Feb 28, 2022 10:00 am ET

The Law Offices of Frank R. Cruz Announces the Filing of a Securities Class Action on Behalf of Talis Biomedical Corporation (TLIS) Investors

LOS ANGELES, Feb. 28, 2022 /PRNewswire/ -- The Law Offices of Frank R. Cruz announces that a class action lawsuit has been filed on behalf of persons and entities that purchased or otherwise acquired Talis Biomedical Corporation ("Talis" or the "Company") (NASDAQ: TLIS) common stock pursuant and/or traceable to the registration statement and prospectus (collectively, the "Registration Statement") issued in connection with the Company's February 2021 initial public offering ("IPO" or the "Offering"). Talis investors have until March 8, 2022 to file a lead plaintiff motion.

Feb 28, 2022 09:02 am ET

Kessler Topaz Meltzer & Check, LLP Reminds Investors of Deadline in Securities Fraud Class Action Lawsuit Filed Against Talis Biomedical Corporation

RADNOR, Pa., Feb. 28, 2022 /PRNewswire/ -- The law firm of Kessler Topaz Meltzer & Check, LLP (www.ktmc.com) informs investors that a securities class action lawsuit has been filed against Talis Biomedical Corporation ("Talis") (NASDAQ: TLIS). The action charges Talis with violations of the federal securities laws, including omissions and fraudulent misrepresentations relating to the company's business, operations, and prospects. As a result of Talis' materially misleading statements to the public, Talis investors have suffered significant losses.

Feb 28, 2022 05:00 am ET

CLASS ACTION ALERT: The Law Offices of Vincent Wong Remind Talis Investors of a Lead Plaintiff Deadline of March 8, 2022

NEW YORK, Feb. 28, 2022 /PRNewswire/ -- Attention Talis Biomedical Corporation ("Talis") (NASDAQ: TLIS) shareholders:

Feb 25, 2022 03:00 pm ET

DEADLINE ALERT for BHG, TLIS, FSLR, TALK, and TALKW: The Law Offices of Frank R. Cruz Reminds Investors of Class Actions on Behalf of Shareholders

The Law Offices of Frank R. Cruz reminds investors that class action lawsuits have been filed on behalf of shareholders of the following publicly-traded companies. Investors have until the deadlines listed below to file a lead plaintiff motion....

Feb 25, 2022 05:00 am ET

TLIS SHAREHOLDER ALERT: Jakubowitz Law Reminds Talis Shareholders of a Lead Plaintiff Deadline of March 8, 2022

NEW YORK, Feb. 25, 2022 /PRNewswire/ -- Jakubowitz Law announces that a securities fraud class action lawsuit has commenced on behalf of shareholders of Talis Biomedical Corporation (NASDAQ: TLIS).

Feb 24, 2022 05:00 am ET

TLIS LAWSUIT ALERT: Levi & Korsinsky Notifies Talis Biomedical Corporation Investors of a Class Action Lawsuit and Upcoming Deadline

NEW YORK, Feb. 24, 2022 /PRNewswire/ -- Levi & Korsinsky, LLP notifies investors in Talis Biomedical Corporation ("Talis" or the "Company") (NASDAQ: TLIS) of a class action securities lawsuit.

Feb 23, 2022 09:00 pm ET

Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Talis, Talkspace, eHealth, and Oak Street and Encourages Investors to Contact the Firm

Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, reminds investors that class actions have been commenced on behalf of stockholders of Talis Biomedical Corporation (NASDAQ: TLIS), Talkspace, Inc. (NASDAQ: TALK),...

Feb 23, 2022 07:26 pm ET

Lead Plaintiff Deadline Approaching: Kessler Topaz Meltzer & Check, LLP Announces Deadline in Securities Fraud Class Action Lawsuit Filed Against Talis Biomedical Corporation

Feb 23, 2022 01:00 pm ET

DEADLINE ALERT for INSD, MMAT, BHG, TLIS: Law Offices of Howard G. Smith Reminds Investors of Class Actions on Behalf of Shareholders

Feb 23, 2022 11:45 am ET

ROSEN, LEADING AND LONGSTANDING INVESTOR COUNSEL, Encourages Talis Biomedical Corporation Investors with Losses Exceeding $100K to Secure Counsel Before Important March 8 Deadline in Securities Class

Feb 23, 2022 10:00 am ET

MMAT, BHG & TLIS: Bronstein, Gewirtz & Grossman, LLC, A Nationally Recognized Firm Reminds Shareholders of Class Action and Lead Plaintiff Deadlines

Feb 23, 2022 05:00 am ET

SHAREHOLDER ALERT: The Gross Law Firm Notifies Shareholders of Talis Biomedical Corporation of a Class Action Lawsuit and a Lead Plaintiff Deadline of March 8, 2022 - (NASDAQ: TLIS)

NEW YORK, Feb. 23, 2022 /PRNewswire/ -- The Gross Law Firm issues the following notice on behalf of shareholders of Talis Biomedical Corporation.

Feb 22, 2022 02:30 pm ET

Pomerantz Law Firm Announces the Filing of a Class Action Against Talis Biomedical Corporation and Certain Officers and Directors – TLIS

Pomerantz LLP announces that a class action lawsuit has been filed against Talis Biomedical Corporation (“Talis” or the “Company”) (NASDAQ: TLIS) and certain of its officers and directors. The class action, filed in the United States District...

Feb 22, 2022 09:31 am ET

HAGENS BERMAN, NATIONAL TRIAL ATTORNEYS, Encourages Talis Biomedical Corporation (TLIS) Investors with Losses to Contact Firm’s Attorneys, Deadline Approaching in Securities Class Action

Feb 22, 2022 09:00 am ET

TLIS Investors Have Opportunity to Lead Talis Biomedical Corporation Securities Fraud Lawsuit

BENSALEM, Pa., Feb. 22, 2022 /PRNewswire/ -- Law Offices of Howard G. Smith announces that investors with substantial losses have opportunity to lead the securities fraud class action lawsuit against Talis Biomedical Corporation ("Talis" or the "Company") (NASDAQ: TLIS).

Feb 22, 2022 08:25 am ET

Investor Notice: March 8th Deadline for Investors who Lost over $100,000 in Talis Biomedical Corporation shares announced by Shareholders Foundation

SAN DIEGO, Feb. 22, 2022 /PRNewswire/ -- The Shareholders Foundation, Inc. announced that a deadline is coming up on March 8, 2022, in the lawsuit that was filed for certain investors in (NASDAQ: TLIS) shares.

Feb 22, 2022 05:00 am ET

CLASS ACTION ALERT: The Law Offices of Vincent Wong Remind Talis Investors of a Lead Plaintiff Deadline of March 8, 2022

NEW YORK, Feb. 22, 2022 /PRNewswire/ -- Attention Talis Biomedical Corporation ("Talis") (NASDAQ: TLIS) shareholders:

Feb 21, 2022 02:00 pm ET

ROSEN, GLOBALLY RESPECTED INVESTOR COUNSEL, Encourages Talis Biomedical Corporation Investors with Losses to Secure Counsel Before Important Deadline in Securities Class Action - TLIS

NEW YORK, Feb. 21, 2022 /PRNewswire/ --

Feb 20, 2022 05:03 pm ET

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Talis Biomedical Corporation - TLIS

NEW YORK, Feb. 20, 2022 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Talis Biomedical Corporation ("Talis" or the "Company") (NASDAQ: TLIS). Such investors are advised to contact Robert S. Willoughby at [email protected] or 888-476-6529, ext. 7980.

Feb 19, 2022 03:54 pm ET

TLIS Reminder: Kessler Topaz Meltzer & Check, LLP - March 8, 2022 Lead Plaintiff Deadline Reminder for Talis Biomedical Corporation Investors

RADNOR, Pa., Feb. 19, 2022 /PRNewswire/ -- The law firm of Kessler Topaz Meltzer & Check, LLP (www.ktmc.com) informs investors that a securities class action lawsuit has been filed against Talis Biomedical Corporation ("Talis") (NASDAQ: TLIS). The action charges Talis with violations of the federal securities laws, including omissions and fraudulent misrepresentations relating to the company's business, operations, and prospects. As a result of Talis' materially misleading statements to the public, Talis investors have suffered significant losses.

Feb 18, 2022 09:00 pm ET

Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Bright Health, First Solar, Talis, and Talkspace and Encourages Investors to Contact the Firm

Feb 18, 2022 06:54 pm ET

ROSEN, A LEADING LAW FIRM, Encourages Talis Biomedical Corporation Investors with Losses to Secure Counsel Before Important Deadline in Securities Class Action – TLIS

Feb 18, 2022 08:30 am ET

TLIS SHAREHOLDER ALERT: Jakubowitz Law Reminds Talis Shareholders of a Lead Plaintiff Deadline of March 8, 2022

NEW YORK, Feb. 18, 2022 /PRNewswire/ -- Jakubowitz Law announces that a securities fraud class action lawsuit has commenced on behalf of shareholders of Talis Biomedical Corporation (NASDAQ: TLIS).

Feb 17, 2022 08:30 am ET

TLIS LAWSUIT ALERT: Levi & Korsinsky Notifies Talis Biomedical Corporation Investors of a Class Action Lawsuit and Upcoming Deadline

NEW YORK, Feb. 17, 2022 /PRNewswire/ -- Levi & Korsinsky, LLP notifies investors in Talis Biomedical Corporation ("Talis" or the "Company") (NASDAQ: TLIS) of a class action securities lawsuit.

Feb 16, 2022 10:15 pm ET

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Talis Biomedical Corporation - TLIS

Pomerantz LLP is investigating claims on behalf of investors of Talis Biomedical Corporation (“Talis” or the “Company”) (NASDAQ: TLIS). Such investors are advised to contact Robert S. Willoughby at [email protected] or 888-476-6529, ext. 7980....

Feb 16, 2022 02:00 pm ET

DEADLINE ALERT for INSD, MMAT, BHG, TLIS: Law Offices of Howard G. Smith Reminds Investors of Class Actions on Behalf of Shareholders

Feb 16, 2022 10:39 am ET

MMAT, BHG & TLIS: Bronstein, Gewirtz & Grossman, LLC, A Nationally Recognized Firm Reminds Shareholders of Class Action and Lead Plaintiff Deadlines

Feb 16, 2022 09:00 am ET

Talis Biomedical Corporation Investors: Please contact the Portnoy Law Firm to recover losses

The Portnoy Law Firm advises Talis Biomedical Corporation (“Talis” or the “Company”) (NASDAQ: TLIS) investors that a class action lawsuit filed on behalf of investors that purchased Talis shares pursuant to the Company’s February 2021 initial...

Feb 16, 2022 08:30 am ET

SHAREHOLDER ALERT: The Gross Law Firm Notifies Shareholders of Talis Biomedical Corporation of a Class Action Lawsuit and a Lead Plaintiff Deadline of March 8, 2022 - (NASDAQ: TLIS)

NEW YORK, Feb. 16, 2022 /PRNewswire/ -- The Gross Law Firm issues the following notice on behalf of shareholders of Talis Biomedical Corporation.

Feb 15, 2022 08:29 pm ET

Investor Reminder: Kessler Topaz Meltzer & Check, LLP Reminds Investors of Securities Fraud Class Action Lawsuit Filed Against Talis Biomedical Corporation – TLIS

Feb 15, 2022 08:30 am ET

TLIS ALERT: The Klein Law Firm Announces a Lead Plaintiff Deadline of March 8, 2022 in the Class Action Filed on Behalf of Talis Biomedical Corporation Shareholders

NEW YORK, Feb. 15, 2022 /PRNewswire/ -- The Klein Law Firm announces that a class action complaint has been filed on behalf of shareholders of Talis Biomedical Corporation (NASDAQ: TLIS) alleging that the Company violated federal securities laws.

Feb 14, 2022 08:28 pm ET

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Talis Biomedical Corporation - TLIS

NEW YORK, Feb. 14, 2022 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Talis Biomedical Corporation ("Talis" or the "Company") (NASDAQ: TLIS). Such investors are advised to contact Robert S. Willoughby at [email protected] or 888-476-6529, ext. 7980.

Feb 14, 2022 11:00 am ET

DEADLINE ALERT for BHG, TLIS, FSLR, TALK, and TALKW: The Law Offices of Frank R. Cruz Reminds Investors of Class Actions on Behalf of Shareholders

Feb 14, 2022 09:37 am ET

TLIS DEADLINE ALERT: Hagens Berman, National Trial Attorneys, Encourages Talis Biomedical Corporation (TLIS) Investors with Losses to Contact Firm’s Attorneys About Lead Plaintiff Opportunity

Feb 14, 2022 08:30 am ET

CLASS ACTION ALERT: The Law Offices of Vincent Wong Remind Talis Investors of a Lead Plaintiff Deadline of March 8, 2022

NEW YORK, Feb. 14, 2022 /PRNewswire/ -- Attention Talis Biomedical Corporation ("Talis") (NASDAQ: TLIS) shareholders:

Feb 13, 2022 09:00 pm ET

Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Meta Materials, Bright Health, First Solar, and Talis and Encourages Investors to Contact the Firm

Feb 11, 2022 02:40 pm ET

TLIS CLASS ACTION: Kessler Topaz Meltzer & Check, LLP Reminds Talis Biomedical Corporation Shareholders of Securities Fraud Class Action Lawsuit

RADNOR, Pa., Feb. 11, 2022 /PRNewswire/ -- The law firm of Kessler Topaz Meltzer & Check, LLP (www.ktmc.com) informs investors that a securities class action lawsuit has been filed against Talis Biomedical Corporation ("Talis") (NASDAQ: TLIS). The action charges Talis with violations of the federal securities laws, including omissions and fraudulent misrepresentations relating to the company's business, operations, and prospects. As a result of Talis' materially misleading statements to the public, Talis investors have suffered significant losses.

Feb 11, 2022 05:00 am ET

TLIS SHAREHOLDER ALERT: Jakubowitz Law Reminds Talis Shareholders of a Lead Plaintiff Deadline of March 8, 2022

NEW YORK, Feb. 11, 2022 /PRNewswire/ -- Jakubowitz Law announces that a securities fraud class action lawsuit has commenced on behalf of shareholders of Talis Biomedical Corporation (NASDAQ: TLIS).

Feb 10, 2022 07:39 pm ET

ROSEN, GLOBAL INVESTOR COUNSEL, Encourages Talis Biomedical Corporation Investors with Losses to Secure Counsel Before Important March 8 Deadline in Securities Class Action - TLIS

NEW YORK, Feb. 10, 2022 /PRNewswire/ --

Feb 10, 2022 03:00 pm ET

Glancy Prongay & Murray LLP Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Talis Biomedical Corporation (TLIS)

Feb 10, 2022 10:35 am ET

MMAT, BHG & TLIS: Bronstein, Gewirtz & Grossman, LLC, A Nationally Recognized Firm Reminds Shareholders of Class Action and Lead Plaintiff Deadlines

Feb 10, 2022 05:00 am ET

TLIS LAWSUIT ALERT: Levi & Korsinsky Notifies Talis Biomedical Corporation Investors of a Class Action Lawsuit and Upcoming Deadline

NEW YORK, Feb. 10, 2022 /PRNewswire/ -- Levi & Korsinsky, LLP notifies investors in Talis Biomedical Corporation ("Talis" or the "Company") (NASDAQ: TLIS) of a class action securities lawsuit.

Feb 09, 2022 05:00 am ET

SHAREHOLDER ALERT: The Gross Law Firm Notifies Shareholders of Talis Biomedical Corporation of a Class Action Lawsuit and a Lead Plaintiff Deadline of March 8, 2022 - (NASDAQ: TLIS)

NEW YORK, Feb. 9, 2022 /PRNewswire/ -- The Gross Law Firm issues the following notice on behalf of shareholders of Talis Biomedical Corporation.

Feb 08, 2022 05:46 pm ET

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Talis Biomedical Corporation - TLIS

Feb 08, 2022 12:00 pm ET

DEADLINE ALERT for INSD, MMAT, BHG, TLIS: Law Offices of Howard G. Smith Reminds Investors of Class Actions on Behalf of Shareholders

Feb 08, 2022 05:00 am ET

TLIS ALERT: The Klein Law Firm Announces a Lead Plaintiff Deadline of March 8, 2022 in the Class Action Filed on Behalf of Talis Biomedical Corporation Shareholders

NEW YORK, Feb. 8, 2022 /PRNewswire/ -- The Klein Law Firm announces that a class action complaint has been filed on behalf of shareholders of Talis Biomedical Corporation (NASDAQ: TLIS) alleging that the Company violated federal securities laws.

Feb 07, 2022 09:00 pm ET

Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against First Solar, Talis, Talkspace, and eHealth and Encourages Investors to Contact the Firm

Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, reminds investors that class actions have been commenced on behalf of stockholders of First Solar, Inc. (NASDAQ: FSLR), Talis Biomedical Corporation (NASDAQ: TLIS),...

Feb 07, 2022 06:53 pm ET

TLIS INVESTOR ALERT: Hagens Berman, National Trial Attorneys, Encourages Talis Biomedical Corporation (TLIS) Investors with Losses to Contact Firm’s Attorneys, Securities Fraud Action Pending

Feb 07, 2022 05:27 pm ET

Kessler Topaz Meltzer & Check, LLP Reminds Talis Biomedical Corporation Investors of Important Deadline in Securities Fraud Class Action Lawsuit and Encourages Investors with Substantial Losses to Con

Feb 07, 2022 02:00 pm ET

DEADLINE ALERT for BHG, TLIS, FSLR, TALK, and TALKW: The Law Offices of Frank R. Cruz Reminds Investors of Class Actions on Behalf of Shareholders

Feb 07, 2022 05:00 am ET

CLASS ACTION ALERT: The Law Offices of Vincent Wong Remind Talis Investors of a Lead Plaintiff Deadline of March 8, 2022

NEW YORK, Feb. 7, 2022 /PRNewswire/ -- Attention Talis Biomedical Corporation ("Talis") (NASDAQ: TLIS) shareholders:

Feb 05, 2022 06:34 am ET

ROSEN, SKILLED INVESTOR COUNSEL, Encourages Talis Biomedical Corporation Investors With Losses Over $100K to Secure Counsel Before Important March 8 Deadline in Securities Class Action – TLIS

Feb 04, 2022 05:31 pm ET

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Talis Biomedical Corporation - TLIS

NEW YORK, Feb. 4, 2022 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Talis Biomedical Corporation ("Talis" or the "Company") (NASDAQ: TLIS). Such investors are advised to contact Robert S. Willoughby at [email protected] or 888-476-6529, ext. 7980.

Feb 04, 2022 01:28 pm ET

Kirby McInerney LLP Reminds Investors That a Securities Class Action Lawsuit Has Been Filed on Behalf of Talis Biomedical Corporation (TLIS) Investors and Encourages Investors to Contact the Firm Befo

The law firm of Kirby McInerney LLP reminds investors that a class action lawsuit has been filed in the U.S. District Court for the Northern District of California on behalf of those who acquired Talis Biomedical Corporation (“Talis” or the “Company”) (NASDAQ:

Feb 04, 2022 11:30 am ET

TLIS Investors Have Opportunity to Lead Talis Biomedical Corporation Securities Fraud Lawsuit

LOS ANGELES, Feb. 4, 2022 /PRNewswire/ -- Glancy Prongay & Murray LLP ("GPM") announces that investors with substantial losses have opportunity to lead the securities fraud class action lawsuit against Talis Biomedical Corporation ("Talis" or the "Company") (NASDAQ: TLIS).

Feb 04, 2022 05:00 am ET

TLIS SHAREHOLDER ALERT: Jakubowitz Law Reminds Talis Shareholders of a Lead Plaintiff Deadline of March 8, 2022

NEW YORK, Feb. 4, 2022 /PRNewswire/ -- Jakubowitz Law announces that a securities fraud class action lawsuit has commenced on behalf of shareholders of Talis Biomedical Corporation (NASDAQ: TLIS).

Feb 02, 2022 09:00 pm ET

Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Bumble, Talis, Talkspace, and eHealth and Encourages Investors to Contact the Firm

Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, reminds investors that class actions have been commenced on behalf of stockholders of Bumble, Inc. (NASDAQ: BMBL), Talis Biomedical Corporation (NASDAQ: TLIS),...

Feb 02, 2022 03:28 pm ET

TLIS LAWSUIT ALERT: Levi & Korsinsky Notifies Talis Biomedical Corporation Investors of a Class Action Lawsuit and Upcoming Deadline

NEW YORK, Feb. 2, 2022 /PRNewswire/ -- Levi & Korsinsky, LLP notifies investors in Talis Biomedical Corporation ("Talis" or the "Company") (NASDAQ: TLIS) of a class action securities lawsuit.

Feb 01, 2022 06:22 pm ET

ROSEN, A LEADING LAW FIRM, Encourages Talis Biomedical Corporation Investors to Secure Counsel Before Important March 8 Deadline in Securities Class Action - TLIS

NEW YORK, Feb. 1, 2022 /PRNewswire/ --

Feb 01, 2022 01:04 pm ET

TALIS BIOMEDICAL CORPORATION CLASS ACTION ALERT: Wolf Haldenstein Adler Freeman & Herz LLP announces that a securities class action lawsuit has been filed against Talis Biomedical Corporation in the U

Wolf Haldenstein Adler Freeman & Herz LLP announces that a federal securities class action lawsuit has been in the United States District Court for the Northern District of California on behalf of persons and entities that purchased or otherwise...

Feb 01, 2022 01:00 pm ET

The Law Offices of Frank R. Cruz Announces the Filing of a Securities Class Action on Behalf of Talis Biomedical Corporation (TLIS) Investors

LOS ANGELES, Feb. 1, 2022 /PRNewswire/ -- The Law Offices of Frank R. Cruz announces that a class action lawsuit has been filed on behalf of persons and entities that purchased or otherwise acquired Talis Biomedical Corporation ("Talis" or the "Company") (NASDAQ: TLIS) common stock pursuant and/or traceable to the registration statement and prospectus (collectively, the "Registration Statement") issued in connection with the Company's February 2021 initial public offering ("IPO" or the "Offering"). Talis investors have until March 8, 2022 to file a lead plaintiff motion.

Feb 01, 2022 12:31 pm ET

TLIS ALERT: The Klein Law Firm Announces a Lead Plaintiff Deadline of March 8, 2022 in the Class Action Filed on Behalf of Talis Biomedical Corporation Limited Shareholders

NEW YORK, Feb. 1, 2022 /PRNewswire/ -- The Klein Law Firm announces that a class action complaint has been filed on behalf of shareholders of Talis Biomedical Corporation (NASDAQ: TLIS) alleging that the Company violated federal securities laws.

Jan 31, 2022 08:21 pm ET

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Talis Biomedical Corporation - TLIS

Jan 31, 2022 02:34 pm ET

MMAT, BHG & TLIS: Bronstein, Gewirtz & Grossman, LLC, A Nationally Recognized Firm Reminds Shareholders of Class Action and Lead Plaintiff Deadlines

Attorney Advertising--Bronstein, Gewirtz & Grossman, LLC reminds investors that a class action lawsuit has been filed against the following publicly-traded companies. You can review a copy of the Complaints by visiting the links below or you may...

Jan 31, 2022 01:35 pm ET

TLIS INVESTOR ALERT: Hagens Berman, National Trial Attorneys, Encourages Talis Biomedical Corporation (TLIS) Investors with Losses to Contact Firm’s Attorneys, Securities Class Action Filed

Jan 31, 2022 12:53 pm ET

CLASS ACTION ALERT: The Law Offices of Vincent Wong Remind Talis Investors of a Lead Plaintiff Deadline of March 8, 2022

NEW YORK, Jan. 31, 2022 /PRNewswire/ -- Attention Talis Biomedical Corporation ("Talis") (NASDAQ: TLIS) shareholders:

Jan 31, 2022 11:00 am ET

DEADLINE ALERT for INSD, MMAT, BHG, TLIS: Law Offices of Howard G. Smith Reminds Investors of Class Actions on Behalf of Shareholders

Jan 30, 2022 09:15 pm ET

Kessler Topaz Meltzer & Check, LLP Reminds Talis Biomedical Corporation (TLIS) Investors of Class Action Lawsuit and Urges Investors with Substantial Losses to Contact the Firm

Jan 29, 2022 01:08 pm ET

ROSEN, GLOBAL INVESTOR COUNSEL, Encourages Talis Biomedical Corporation Investors With Losses to Secure Counsel Before Important March 8 Deadline in Securities Class Action – TLIS

Jan 28, 2022 09:00 pm ET

Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Talis Biomedical and Oak Street and Encourages Investors to Contact the Firm

Jan 28, 2022 06:28 pm ET

Kirby McInerney LLP Reminds Investors That a Securities Class Action Lawsuit Has Been Filed on Behalf of Talis Biomedical Corporation (TLIS) Investors and Encourages Investors to Contact the Firm Befo

Jan 28, 2022 01:07 pm ET

TLIS SHAREHOLDER ALERT: Jakubowitz Law Reminds Talis Shareholders of a Lead Plaintiff Deadline of March 8, 2022

NEW YORK, Jan. 28, 2022 /PRNewswire/ -- Jakubowitz Law announces that a securities fraud class action lawsuit has commenced on behalf of shareholders of Talis Biomedical Corporation (NASDAQ: TLIS).

Jan 28, 2022 01:00 pm ET

Glancy Prongay & Murray LLP Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Talis Biomedical Corporation (TLIS)

Jan 27, 2022 05:50 pm ET

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Talis Biomedical Corporation - TLIS

NEW YORK, Jan. 27, 2022 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Talis Biomedical Corporation ("Talis" or the "Company") (NASDAQ: TLIS). Such investors are advised to contact Robert S. Willoughby at [email protected] or 888-476-6529, ext. 7980.

Jan 27, 2022 01:15 pm ET

SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Shareholders of Talis Biomedical Corporation of a Class Action Lawsuit and a Lead Plaintiff Deadline of March 8, 2022 - TLIS

NEW YORK, Jan. 27, 2022 /PRNewswire/ -- The following statement is being issued by Levi & Korsinsky, LLP:

Jan 27, 2022 11:30 am ET

DEADLINE ALERT for BHG, TLIS, FSLR, TALK, and TALKW: The Law Offices of Frank R. Cruz Reminds Investors of Class Actions on Behalf of Shareholders

Jan 26, 2022 07:52 pm ET

SHAREHOLDER ALERT: The Gross Law Firm Notifies Shareholders of Talis Biomedical Corporation of a Class Action Lawsuit and a Lead Plaintiff Deadline of March 8, 2022 - (TLIS)

NEW YORK, Jan. 26, 2022 /PRNewswire/ -- The Gross Law Firm, securities class action litigators, issues the following notice to shareholders of Talis Biomedical Corporation.

Jan 26, 2022 04:18 pm ET

TALIS BIOMEDICAL CORPORATION (NASDAQ: TLIS) SHAREHOLDER CLASS ACTION ALERT: Bernstein Liebhard LLP Reminds Investors of the Deadline to File a Lead Plaintiff Motion in a Securities Class Action Lawsui

NEW YORK, Jan. 26, 2022 /PRNewswire/ -- Bernstein Liebhard LLP, a nationally acclaimed investor rights law firm, reminds investors of the deadline to file a lead plaintiff motion in a securities class action lawsuit that has been filed on behalf of investors who purchased or acquired common stock of Talis Biomedical Corporation (the "Company" or "Talis") (NASDAQ: TLIS) in connection with Talis' February 12, 2021 initial public offering (the "IPO"). The lawsuit was filed in the United States District Court for the Northern District of California and alleges violations of the Securities Excha

Jan 26, 2022 10:00 am ET

TLIS Investors Have Opportunity to Lead Talis Biomedical Corporation Securities Fraud Lawsuit

BENSALEM, Pa., Jan. 26, 2022 /PRNewswire/ -- Law Offices of Howard G. Smith announces that investors with substantial losses have opportunity to lead the securities fraud class action lawsuit against Talis Biomedical Corporation ("Talis" or the "Company") (NASDAQ: TLIS).

Jan 24, 2022 09:37 am ET

TLIS INVESTOR FRAUD: Hagens Berman, National Trial Attorneys, Encourages Talis Biomedical Corporation (TLIS) Investors with Losses to Contact Firm’s Attorneys, Securities Class Action Filed

Jan 23, 2022 09:00 pm ET

Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Talis Biomedical, Oak Street Health, Instadose, and Bright Health and Encourages Investors to Contact t

Jan 23, 2022 10:28 am ET

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Talis Biomedical Corporation - TLIS

Jan 22, 2022 04:50 pm ET

TLIS Reminder: Kessler Topaz Meltzer & Check, LLP Reminder for Talis Biomedical Corporation Investors of Securities Fraud Class Action Lawsuit

Jan 21, 2022 04:44 pm ET

INVESTOR ALERT: Kirby McInerney LLP Reminds Investors That a Securities Class Action Lawsuit Has Been Filed on Behalf of Talis Biomedical Corporation (TLIS) Investors and Encourages Investors to Conta

Jan 21, 2022 11:15 am ET

DEADLINE ALERT for BHG, TLIS, FSLR, TALK, and TALKW: The Law Offices of Frank R. Cruz Reminds Investors of Class Actions on Behalf of Shareholders

Jan 21, 2022 11:00 am ET

DEADLINE ALERT for INSD, MMAT, BHG, TLIS: Law Offices of Howard G. Smith Reminds Investors of Class Actions on Behalf of Shareholders

Jan 20, 2022 05:39 pm ET

ROSEN, RESPECTED INVESTOR COUNSEL, Encourages Talis Biomedical Corporation Investors to Secure Counsel Before Important March 8 Deadline in Securities Class Action - TLIS

NEW YORK, Jan. 20, 2022 /PRNewswire/ --

Jan 20, 2022 04:29 pm ET

TLIS ALERT: Levi & Korsinsky, LLP Reminds Shareholders of Talis Biomedical Corporation of a Class Action Lawsuit and a Lead Plaintiff Deadline of March 8, 2022 - TLIS

NEW YORK, Jan. 20, 2022 /PRNewswire/ -- The following statement is being issued by Levi & Korsinsky, LLP:

Jan 18, 2022 03:12 pm ET

Shareholder Alert: Robbins LLP Reminds Investors that Talis Biomedical Corporation (TLIS) is Being Sued for Misleading Shareholders

Shareholder rights law firm Robbins LLP reminds investors that a shareholder filed a class action on behalf of all persons and entities that purchased or otherwise acquired Talis Biomedical Corporation (NASDAQ: TLIS) common stock pursuant to or traceable to the Company’s February 2021 initial public offering ("IPO"). T

Jan 18, 2022 01:22 pm ET

HAGENS BERMAN, NATIONAL TRIAL ATTORNEYS, Encourages Talis Biomedical Corporation (TLIS) Investors with Losses to Contact Firm’s Attorneys, IPO-Related Securities Class Action Filed

Jan 17, 2022 09:00 pm ET

Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Meta Materials, Talis, FirstCash, and Oak Street Health and Encourages Investors to Contact the Firm

Jan 17, 2022 08:22 pm ET

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Talis Biomedical Corporation - TLIS

NEW YORK, Jan. 17, 2022 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Talis Biomedical Corporation ("Talis" or the "Company") (NASDAQ: TLIS). Such investors are advised to contact Robert S. Willoughby at [email protected] or 888-476-6529, ext. 7980.

Jan 17, 2022 11:00 am ET

TLIS Investor Alert: Bronstein, Gewirtz & Grossman, LLC Notifies Talis Biomedical Corporation Shareholders of Class Action and Lead Deadline: March 8, 2022

Attorney Advertising--Bronstein, Gewirtz & Grossman, LLC notifies investors that a class action lawsuit has been filed against Talis Biomedical Corporation ("Talis" or the "Company") (NASDAQ: TLIS) and certain of its officers, on behalf of shareholders who purchased or otherwise acquired Talis common stock pursuant and/or traceable to the registration statement and prospectus (collectively, the "Registration Statement") issued in connection with the Company’s February 2021 initial public offering ("IPO" or the "Offering"). Such investors are encouraged to join this case by visiting the firm’s

Jan 16, 2022 06:12 pm ET

Kessler Topaz Meltzer & Check, LLP Reminds Investors of Securities Fraud Class Action Lawsuit against Talis Biomedical Corporation and Encourages Investors with Substantial Losses to Contact the Firm

The law firm of Kessler Topaz Meltzer & Check, LLP informs investors that a securities class action lawsuit has been filed against Talis Biomedical Corporation (“Talis”) (

Jan 15, 2022 05:01 pm ET

TLIS ALERT: Talis Biomedical Corp. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit

SAN DIEGO, Jan. 15, 2022 /PRNewswire/ -- Robbins Geller Rudman & Dowd LLP announces that purchasers or acquirers of Talis Biomedical Corporation (NASDAQ: TLIS) common stock pursuant and/or traceable to the registration statement and prospectus (collectively, the "Registration Statement") issued in connection with Talis Biomedical's February 12, 2021 initial public offering ("IPO") have until March 8, 2022 to seek appointment as lead plaintiff in Modrak v. Talis Biomedical Corporation, No. 22-cv-00105 (N.D. Cal.). Commenced on January 7, 2022 and pending before Judge Susan Illston, the Ta

Jan 15, 2022 01:04 pm ET

Kessler Topaz Meltzer & Check, LLP: Securities Fraud Class Action Lawsuit Filed Against Talis Biomedical Corporation

RADNOR, Pa., Jan. 15, 2022 /PRNewswire/ -- The law firm of Kessler Topaz Meltzer & Check, LLP informs investors that a securities class action lawsuit has been filed against Talis Biomedical Corporation ("Talis") (NASDAQ: TLIS). The action charges Talis with violations of the federal securities laws, including omissions and fraudulent misrepresentations relating to the company's business, operations, and prospects. As a result of Talis' materially misleading statements to the public, Talis investors have suffered significant losses.

Jan 14, 2022 08:10 pm ET

Kessler Topaz Meltzer & Check, LLP Announces a Securities Fraud Class Action Filed Against Talis Biomedical Corporation (TLIS)

The law firm of Kessler Topaz Meltzer & Check, LLP informs investors that a securities class action lawsuit has been filed in the United States District Court for the Northern District of California against Talis Biomedical Corporation (“Talis”)...

Jan 14, 2022 03:35 pm ET

NATIONALLY RANKED ROSEN LAW FIRM Encourages Talis Biomedical Corporation Investors with Losses in Excess of $100K to Secure Counsel Before Important Deadline in Securities Class Action – TLIS

Jan 14, 2022 01:57 pm ET

TALIS BIOMEDICAL CORPORATION CLASS ACTION ALERT: Wolf Haldenstein Adler Freeman & Herz LLP announces that a securities class action lawsuit has been filed against Talis Biomedical Corporation in the U

Jan 14, 2022 11:05 am ET

DEADLINE ALERT for BHG, TLIS, FSLR, TALK, and TALKW: The Law Offices of Frank R. Cruz Reminds Investors of Class Actions on Behalf of Shareholders

Jan 13, 2022 04:57 pm ET

INVESTOR ALERT: Kirby McInerney LLP Announces the Filing of a Securities Class Action on Behalf of Talis Biomedical Corporation (TLIS) Investors

Jan 13, 2022 01:30 pm ET

TALIS BIOMEDICAL CORPORATION (NASDAQ: TLIS) SHAREHOLDER CLASS ACTION ALERT: Bernstein Liebhard LLP Announces that a Securities Class Action Lawsuit Has Been Filed Against Talis Biomedical Corporation

Bernstein Liebhard LLP announces that a securities class action lawsuit has been filed on behalf of investors who purchased or acquired common stock of Talis Biomedical Corporation (the “Company” or “Talis”) (NASDAQ: TLIS) in connection with Talis’...

Jan 13, 2022 11:00 am ET

Deadline Reminder: Law Offices of Howard G. Smith Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Talis Biomedical Corporation (TLIS)

Law Offices of Howard G. Smith reminds investors of the upcoming March 8, 2022 deadline to file a lead plaintiff motion in the case filed on behalf of investors who purchased Talis Biomedical Corporation (“Talis” or the “Company”) (NASDAQ: TLIS) common stock pursuant and/or traceable to the registration statement and prospectus (collectively

Jan 13, 2022 09:16 am ET

TLIS Investor Alert: Bronstein, Gewirtz & Grossman, LLC Notifies Talis Biomedical Corporation Shareholders of Class Action and Lead Deadline: March 8, 2022

Jan 13, 2022 08:21 am ET

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Talis Biomedical Corporation - TLIS

Jan 12, 2022 04:30 pm ET

Shareholder Alert: Robbins LLP Informs Investors that Talis Biomedical Corporation (TLIS) is Being Sued for Misleading Shareholders

Shareholder rights law firm Robbins LLP informs investors that a shareholder filed a class action on behalf of all persons and entities that purchased or otherwise acquired Talis Biomedical Corporation (NASDAQ: TLIS) common stock pursuant to or traceable to the Company’s February 2021 initial public offering ("IPO"). Tali

Jan 12, 2022 11:23 am ET

SHAREHOLDER ACTION ALERT: The Schall Law Firm Encourages Investors in Talis Biomedical Corporation with Losses of $100,000 to Contact the Firm

The Schall Law Firm, a national shareholder rights litigation firm, announces the filing of a class action lawsuit against Talis Biomedical Corporation (“Talis” or “the Company”) (NASDAQ:

Jan 12, 2022 09:16 am ET

TLIS INVESTOR ALERT: Hagens Berman, National Trial Attorneys, Encourages Talis Biomedical Corporation (TLIS) Investors to Contact Firm's Attorneys, IPO-Related Securities Class Action Filed

SAN FRANCISCO, Jan. 12, 2022 /PRNewswire/ -- Hagens Berman urges Talis Biomedical Corporation (NASDAQ: TLIS) investors with losses to submit your losses now.

Jan 11, 2022 07:03 pm ET

HAGENS BERMAN, NATIONAL TRIAL ATTORNEYS, Encourages Talis Biomedical Corporation (TLIS) Investors to Contact Firm’s Attorneys, IPO-Related Securities Class Action Filed

Jan 11, 2022 04:46 pm ET

EQUITY ALERT: ROSEN, A LEADING LAW FIRM, Encourages Talis Biomedical Corporation Investors with Losses Exceeding $100K to Secure Counsel Before Important Deadline in Securities Class Action – TLIS

WHY: Rosen Law Firm, a global investor rights law firm, announces the filing of a class action lawsuit on behalf of purchasers of the securities of Talis Biomedical Corporation (NASDAQ: TLIS) pursuant and/or traceable to the registration statement and prospectus (collectively, the “Registration Statement”) issued in connection with the Company’s February 2021 initial public offering (“IPO” or the “Offering”). A class action lawsuit has already been filed. If you wish to serve as lead plaintiff, you must move the Court no later than March 8, 2022.

Jan 11, 2022 03:04 pm ET

DEADLINE: Talis Biomedical Corporation Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit - TLIS

SAN DIEGO, Jan. 11, 2022 /PRNewswire/ -- The law firm of Robbins Geller Rudman & Dowd LLP announces that purchasers of Talis Biomedical Corporation (NASDAQ: TLIS) common stock pursuant and/or traceable to the registration statement and prospectus (collectively, the "Registration Statement") issued in connection with Talis Biomedical's February 12, 2021 initial public offering ("IPO") have until March 8, 2022 to seek appointment as lead plaintiff in Modrak v. Talis Biomedical Corporation, No. 22-cv-00105 (N.D. Cal.). Commenced on January 7, 2022, the Talis Biomedical class action lawsuit

Jan 11, 2022 01:24 pm ET

SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Shareholders of Talis Biomedical Corporation of a Class Action Lawsuit and a Lead Plaintiff Deadline of March 8, 2022 - TLIS

NEW YORK, Jan. 11, 2022 /PRNewswire/ -- The following statement is being issued by Levi & Korsinsky, LLP:

Jan 11, 2022 12:31 pm ET

TALIS BIOMEDICAL CORPORATION (NASDAQ: TLIS) SHAREHOLDER CLASS ACTION ALERT: Bernstein Liebhard LLP Announces that a Securities Class Action Lawsuit Has Been Filed Against Talis Biomedical Corporation

NEW YORK, Jan. 11, 2022 /PRNewswire/ -- Bernstein Liebhard LLP announces that a securities class action lawsuit has been filed on behalf of investors who purchased or acquired common stock of Talis Biomedical Corporation (the "Company" or "Talis") (NASDAQ: TLIS) in connection with Talis' February 12, 2021 initial public offering (the "IPO"). The lawsuit was filed in the United States District Court for the Northern District of California and alleges violations of the Securities Exchange Act of 1933.

Jan 11, 2022 12:05 pm ET

The Law Offices of Frank R. Cruz Announces the Filing of a Securities Class Action on Behalf of Talis Biomedical Corporation (TLIS) Investors

The Law Offices of Frank R. Cruz announces that a class action lawsuit has been filed on behalf of persons and entities that purchased or otherwise acquired Talis Biomedical Corporation (“Talis” or the “Company”) (NASDAQ:

Jan 11, 2022 11:00 am ET

Glancy Prongay & Murray LLP Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Talis Biomedical Corporation (TLIS)

Jan 11, 2022 09:00 am ET

TLIS Investor Alert: Bronstein, Gewirtz & Grossman, LLC Notifies Talis Biomedical Corporation Shareholders of Class Action and Lead Deadline: March 8, 2022

NEW YORK, Jan. 11, 2022 /PRNewswire/ -- Attorney Advertising -- Bronstein, Gewirtz & Grossman, LLC notifies investors that a class action lawsuit has been filed against Talis Biomedical Corporation ("Talis" or the "Company") (NASDAQ: TLIS) and certain of its officers, on behalf of shareholders who purchased or otherwise acquired Talis common stock pursuant and/or traceable to the registration statement and prospectus (collectively, the "Registration Statement") issued in connection with the Company's February 2021 initial public offering ("IPO" or the "Offering"). Such investors are enco

Jan 10, 2022 05:01 pm ET

TALIS INVESTOR ALERT: Kaplan Fox Investigates Potential Securities Fraud at Talis Biomedical

Kaplan Fox & Kilsheimer LLP (www.kaplanfox.com) is investigating claims on behalf of investors of Talis Biomedical Corporation (“Talis” or the “Company”) (NASDAQ: TLIS), a company that develops diagnostic tests for infectious diseases. Talis...

Jan 10, 2022 01:33 pm ET

ALERT: Talis Biomedical Corporation Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit - TLIS

Jan 10, 2022 12:05 pm ET

TLIS CLASS ACTION NOTICE: The Law Offices of Frank R. Cruz Files Securities Fraud Lawsuit Against Talis Biomedical Corporation

The Law Offices of Frank R. Cruz announces that it has filed a class action lawsuit in the United States District Court for the Northern District of California captioned Modrak v. Talis Biomedical Corporation, et al., (Case No. 22-cv-105) on behalf of persons and entities that purchased or otherwise acquired Talis Biomedic

Jan 10, 2022 12:00 pm ET

INVESTOR ALERT: Law Offices of Howard G. Smith Announces the Filing of a Securities Class Action on Behalf of Talis Biomedical Corporation (TLIS) Investors

Law Offices of Howard G. Smith announces that a class action lawsuit has been filed on behalf of investors who purchased Talis Biomedical Corporation (“Talis” or the “Company”) (NASDAQ: TLIS) common stock pursuant and/or traceable to the registration statement and prospectus (collectively, the “Registration Statement”) issued in connection with the

Jan 09, 2022 09:00 pm ET

Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Meta Materials and Talis Biomedical and Encourages Investors to Contact the Firm

Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, reminds investors that class actions have been commenced on behalf of stockholders of Meta Materials Inc (NASDAQ: MMAT). and Talis Biomedical Corporation (NASDAQ:...

Jan 08, 2022 03:54 pm ET

TALIS BIOMEDICAL CORPORATION SECURITIES CLASS ACTION INVESTIGATION – Class Action Lawsuit Filed On Behalf Of TLIS Investors - Kehoe Law Firm, P.C. Investigating

Kehoe Law Firm, P.C. is investigating whether Talis Biomedical Corporation (“Talis” or the “Company”) (NASDAQ: TLIS) violated federal securities laws. TLIS INVESTORS WHO ACQUIRED THEIR SECURITIES PURSUANT AND/OR TRACEABLE TO THE REGISTRATION...

Jan 08, 2022 06:00 am ET

TALIS BIOMEDICAL SHAREHOLDER ALERT BY FORMER LOUISIANA ATTORNEY GENERAL: Kahn Swick & Foti, LLC Reminds Investors with Losses in Excess of $100,000 of Lead Plaintiff Deadline in Class Action Lawsuit A

NEW ORLEANS, Jan. 8, 2022 /PRNewswire/ -- Kahn Swick & Foti, LLC ("KSF") and KSF partner, former Attorney General of Louisiana, Charles C. Foti, Jr., remind investors that they have until March 8, 2022 to file lead plaintiff applications in a securities class action lawsuit against Talis Biomedical Corporation (NasdaqGM: TLIS), if they purchased the Company's shares issued in connection with its February 2021 initial public stock offering (the "IPO"). This action is pending in the United States District Court for the Northern District of California.

Jan 07, 2022 09:00 pm ET

TALIS BIOMEDICAL ALERT: Bragar Eagel & Squire, P.C. Announces That a Class Action Lawsuit Has Been Filed Against Talis Biomedical Corporation and Encourages Investors to Contact the Firm

Jan 07, 2022 05:04 pm ET

TLIS CLASS ACTION NOTICE: Glancy Prongay & Murray LLP Files Securities Lawsuit Against Talis Biomedical Corporation

Glancy Prongay & Murray LLP (“GPM”), announces that it has filed a class action lawsuit in the United States District Court for the Northern District of California captioned Modrak v. Talis Biomedical Corporation, et al., (Case No. 22-cv-105) on behalf of persons and entities that purchased or otherwise acquired Talis Biome

Jan 06, 2022 05:37 pm ET

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Talis Biomedical Corporation - TLIS

NEW YORK, Jan. 6, 2022 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Talis Biomedical Corporation ("Talis" or the "Company") (NASDAQ: TLIS). Such investors are advised to contact Robert S. Willoughby at [email protected] or 888-476-6529, ext. 7980.

Jan 03, 2022 06:24 pm ET

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Talis Biomedical Corporation - TLIS

Dec 21, 2021 02:00 pm ET

Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm, Continues Its Investigation of Talis Biomedical Corporation (TLIS) on Behalf of Investors

Glancy Prongay & Murray LLP (“GPM”), a leading national shareholder rights law firm, continues its investigation on behalf of Talis Biomedical Corporation (“Talis” or the “Company”) (NASDAQ: TLIS) investors concerning the Company’s possible...

Dec 20, 2021 04:00 pm ET

INVESTOR ALERT: Law Offices of Howard G. Smith Continues Its Investigation of Talis Biomedical Corporation (TLIS) on Behalf of Investors

Law Offices of Howard G. Smith continues its investigation on behalf of Talis Biomedical Corporation (“Talis” or the “Company”) (NASDAQ: TLIS) investors concerning the Company’s possible violations of the federal securities laws. On August 10,...

Dec 13, 2021 10:30 pm ET

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Talis Biomedical Corporation - TLIS

NEW YORK, Dec. 13, 2021 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Talis Biomedical Corporation ("Talis" or the "Company") (NASDAQ: TLIS). Such investors are advised to contact Robert S. Willoughby at [email protected] or 888-476-6529, ext. 7980.

Dec 13, 2021 10:00 am ET

Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm, Continues Its Investigation of Talis Biomedical Corporation (TLIS) on Behalf of Investors

Dec 10, 2021 09:00 am ET

INVESTOR ALERT: Law Offices of Howard G. Smith Continues Its Investigation of Talis Biomedical Corporation (TLIS) on Behalf of Investors

Dec 09, 2021 06:16 pm ET

INVESTOR ALERT: Kirby McInerney LLP Announces an Investigation of Shareholder Claims on Behalf of Talis Biomedical Corporation (TLIS) Investors

The law firm of Kirby McInerney LLP is investigating potential claims against Talis Biomedical Corporation (“Talis” or the “Company”) (NASDAQ: TLIS). The investigation concerns whether Talis has violated the federal securities laws and/or engaged...

Dec 08, 2021 07:30 pm ET

INVESTOR ALERT: Law Offices of Howard G. Smith Continues Its Investigation of Talis Biomedical Corporation (TLIS) on Behalf of Investors

Dec 08, 2021 06:21 pm ET

The Law Offices of Frank R. Cruz Continues Its Investigation of Talis Biomedical Corporation (TLIS) on Behalf of Investors

The Law Offices of Frank R. Cruz continues its investigation on behalf of Talis Biomedical Corporation (“Talis” or the “Company”) (NASDAQ:

Dec 08, 2021 03:51 pm ET

Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm, Continues Its Investigation of Talis Biomedical Corporation (TLIS) on Behalf of Investors

Dec 08, 2021 08:00 am ET

Talis Biomedical Announces Leadership Transition

Dec 03, 2021 02:15 pm ET

The Law Offices of Frank R. Cruz Continues Investigation of Talis Biomedical Corporation (TLIS) on Behalf of Investors

LOS ANGELES, Dec. 3, 2021 /PRNewswire/ -- The Law Offices of Frank R. Cruz continues its investigation of Talis Biomedical Corporation ("Talis" or the "Company") (NASDAQ: TLIS) on behalf of investors concerning the Company's possible violations of federal securities laws.

Dec 03, 2021 09:00 am ET

INVESTOR ALERT: Law Offices of Howard G. Smith Continues Its Investigation of Talis Biomedical Corporation (TLIS) on Behalf of Investors

BENSALEM, Pa., Dec. 3, 2021 /PRNewswire/ -- Law Offices of Howard G. Smith continues its investigation on behalf of Talis Biomedical Corporation ("Talis" or the "Company") (NASDAQ: TLIS) investors concerning the Company's possible violations of the federal securities laws.

Dec 02, 2021 05:53 pm ET

Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm, Continues Its Investigation of Talis Biomedical Corporation (TLIS) on Behalf of Investors

LOS ANGELES, Dec. 2, 2021 /PRNewswire/ -- Glancy Prongay & Murray LLP ("GPM"), a leading national shareholder rights law firm, continues its investigation on behalf of Talis Biomedical Corporation ("Talis" or the "Company") (NASDAQ: TLIS) investors concerning the Company's possible violations of the federal securities laws.

Dec 02, 2021 05:00 pm ET

Talis Biomedical Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Nov 15, 2021 04:05 pm ET

Talis Biomedical Announces Third Quarter 2021 Financial Results and Business Progress

Nov 15, 2021 04:02 pm ET

Talis Biomedical Announces Appointment of Brian Blaser as President, Chief Executive Officer and Director

Nov 12, 2021 12:00 pm ET

Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm, Continues Its Investigation of Talis Biomedical Corporation (TLIS) on Behalf of Investors

Nov 11, 2021 04:00 pm ET

INVESTOR ALERT: Law Offices of Howard G. Smith Continues Its Investigation of Talis Biomedical Corporation (TLIS) on Behalf of Investors

Nov 08, 2021 08:00 am ET

Talis Biomedical Granted FDA Emergency Use Authorization (EUA) for COVID-19 Molecular Point-of-Care Test to Detect SARS-CoV-2

Talis Biomedical Corporation (NASDAQ: TLIS) today announced that the U.S. Food and Drug Administration (FDA) has granted Emergency Use Authorization (EUA) for its Talis One™ COVID-19 Test System - a nucleic acid amplification test (NAAT). The Talis...

Oct 26, 2021 08:00 am ET

Talis Biomedical to Announce Third Quarter 2021 Financial Results on November 15, 2021

Talis Biomedical Corporation ("TLIS"), a company dedicated to developing innovative molecular diagnostic tests for infectious diseases at the point-of-care, today announced that it will release financial results for the third quarter after market...

Sep 14, 2021 04:00 pm ET

Glancy Prongay & Murray LLP, a National Class Action Law Firm, Continues Investigation of Talis Biomedical Corporation (TLIS) on Behalf of Investors

Glancy Prongay & Murray LLP (“GPM”), a national investor rights law firm, continues its investigation on behalf of Talis Biomedical Corporation (“Talis” or the “Company”) (NASDAQ:

Sep 14, 2021 01:32 pm ET

INVESTOR ALERT: Law Offices of Howard G. Smith Continues Investigation of Talis Biomedical Corporation (TLIS) on Behalf of Investors

Law Offices of Howard G. Smith continues its investigation on behalf of Talis Biomedical Corporation (“Talis” or the “Company”) (NASDAQ: TLIS) investors concerning the Company and its officers’ possible violations of federal securities laws.

Sep 13, 2021 07:00 pm ET

TALIS ALERT: Bragar Eagel & Squire, P.C. is Investigating Talis on Behalf of Talis Stockholders and Encourages Investors to Contact the Firm

Bragar Eagel & Squire, P.C., a nationally recognized stockholder rights law firm, is investigating potential claims against Talis Biomedical Corporation (“Talis” or the “Company”) (NASDAQ: TLIS) on behalf of Talis stockholders. Our investigation concerns whether Talis has violated the federal securities laws and/or engaged in other unlawful business practices.

Sep 09, 2021 06:00 pm ET

Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm, Announces Investigation of Talis Biomedical Corporation (TLIS) on Behalf of Investors

Glancy Prongay & Murray LLP (“GPM”), a leading national shareholder rights law firm, today announced that it has commenced an investigation on behalf of Talis Biomedical Corporation (“Talis” or the “Company”) (NASDAQ:

Sep 09, 2021 03:15 pm ET

The Law Offices of Frank R. Cruz Continues Investigation of Talis Biomedical Corporation (TLIS) on Behalf of Investors

The Law Offices of Frank R. Cruz continues its investigation of Talis Biomedical Corporation (“Talis” or the “Company”) (NASDAQ: TLIS) on behalf of investors concerning the Company’s possible violations of federal securities laws.

Sep 03, 2021 08:49 am ET

TLIS Alert: Johnson Fistel Launches Investigation into Talis Biomedical - Stock Price has Plummeted since IPO; Investors Suffering Losses Encouraged to Contact the Firm

Shareholder rights law firm Johnson Fistel, LLP is investigating potential violations of the federal securities laws by Talis Biomedical Corporation ("Talis" or the "Company") (NASDAQ: TLIS). On or about February 12, 2021, Talis sold approximately...

Aug 31, 2021 08:25 pm ET

The Law Offices of Frank R. Cruz Announces Investigation of Talis Biomedical Corporation (TLIS) on Behalf of Investors

The Law Offices of Frank R. Cruz announces an investigation of Talis Biomedical Corporation (“Talis” or the “Company”) (NASDAQ: TLIS) on behalf of investors concerning the Company’s possible violations of federal securities laws.

You are here

Talis Biomedical Corp (OQ:TLIS)

Business Focus: Biotechnology & Medical Research